Literature DB >> 1809377

Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.

G Shaulsky1, N Goldfinger, A Peled, V Rotter.   

Abstract

Transfection of wild-type p53 into a pre-B, p53 nonproducer cell line yielded the generation of stable clones. Although constitutively expressing the growth-suppressor wild-type p53 protein, these cells proliferate continuously in vitro. However, expression of wild-type p53 in these cells altered their cell cycle pattern and reduced their growth in vivo. When the same parental cells were transfected with a plasmid coding for a wild-type p53 lacking nuclear localization signals, a wild-type cytoplasmic p53 protein was expressed. Expression of this cytoplasmic p53 product did not exert any changes in the growth of the parental cells, suggesting that wild-type p53 affects the cell cycle only when localized in the nuclear cell compartment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1809377

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  13 in total

1.  Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells.

Authors:  Attila Bacsi; G John Stanton; Thomas K Hughes; Marian Kruze; Istvan Boldogh
Journal:  Cell Mol Neurobiol       Date:  2005-11       Impact factor: 5.046

2.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

3.  Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.

Authors:  A Kovacs; M L Weber; L J Burns; H S Jacob; G M Vercellotti
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

Authors:  L Wu; J H Bayle; B Elenbaas; N P Pavletich; A J Levine
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

5.  Alteration in p53 modulates glial proteins in human glial tumour cells.

Authors:  H S U; A Banaie; L Rigby; J Chen; H Meltzer
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

6.  Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage.

Authors:  U M Moll; A G Ostermeyer; R Haladay; B Winkfield; M Frazier; G Zambetti
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.

Authors:  O Foord; N Navot; V Rotter
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Authors:  U M Moll; G Riou; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.

Authors:  S Bosari; G Viale; M Roncalli; D Graziani; G Borsani; A K Lee; G Coggi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 10.  Toward a molecular understanding of human breast cancer: a hypothesis.

Authors:  J W Shay; W E Wright; H Werbin
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.